We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00188123
First Posted: September 16, 2005
Last Update Posted: July 15, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Jonkoping County Hospital
Medical Research Council of Southeast Sweden
Information provided by:
University Hospital, Linkoeping
  Purpose
The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique

Condition Phase
Myocardial Infarction Phase 4

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI

Resource links provided by NLM:


Further study details as provided by University Hospital, Linkoeping:

Enrollment: 20
Study Start Date: April 2004
Study Completion Date: April 2009
Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)
Detailed Description:
50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with an in-hospital diagnosis of myocardial infarction having permanent atrial fibrillation.
Criteria

Inclusion Criteria:

in-hospital diagnosis of myocardial infarction

Exclusion Criteria:

pacemaker, not willing to participate, metallic objects in brain or eyes,

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00188123


Locations
Sweden
Varnamo Hospital
Varnamo, Sweden, SE33185
Sponsors and Collaborators
University Hospital, Linkoeping
Jonkoping County Hospital
Medical Research Council of Southeast Sweden
Investigators
Principal Investigator: Jan E Engvall, MD, PhD University Hospital, Linkoeping
  More Information

Responsible Party: Linkoping universitet
ClinicalTrials.gov Identifier: NCT00188123     History of Changes
Other Study ID Numbers: 151:2004/8333 MPA Sweden
First Submitted: September 15, 2005
First Posted: September 16, 2005
Last Update Posted: July 15, 2009
Last Verified: September 2005

Keywords provided by University Hospital, Linkoeping:
Myocardial infarction
MRI late enhancement
Atrial fibrillation

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Coronary Stenosis
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Coronary Disease